<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8112299" created="22/03/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8112299</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="calcineurin" sem="Protein_molecule">Calcineurin</term> acts in synergy with <term id="T2" lex="PMA" sem="Organic_compound_other">PMA</term> to inactivate <term id="T3" lex="I_kappa_B/MAD3" sem="Protein_molecule">I kappa B/MAD3</term>, an inhibitor of <term id="T4" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>.</sentence>
<event id="E1">
<type class="Negative_regulation"/>
<theme idref="T3"/>
<cause idref="T1"/>
<cause idref="T2"/>
<clue>Calcineurin acts <linkCause>in synergy with</linkCause> PMA to <clueType>inactivate</clueType> I kappa B/MAD3, an inhibitor of NF-kappa B.</clue>
</event>
<event KT="Fact" id="E22">
<type class="Negative_regulation"/>
<theme idref="T3"/>
<cause idref="T4"/>
<clue>Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an <clueType>inhibitor</clueType> <linkTheme>of</linkTheme> NF-kappa B.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term id="T5" lex="interleukin-2_(IL-2)_promoter" sem="DNA_domain_or_region"><term id="T6" lex="interleukin-2" sem="Protein_molecule">interleukin-2</term> (<term id="T7" lex="IL-2" sem="Protein_molecule">IL-2</term>) promoter</term> consists of several independent <term id="T8" lex="T_cell_receptor_(TcR)_responsive_element" sem="DNA_family_or_group"><term id="T9" lex="T_cell_receptor" sem="Protein_family_or_group">T cell receptor</term> (<term id="T10" lex="TcR" sem="Protein_family_or_group">TcR</term>) responsive elements</term>.</sentence>
<sentence id="S3">The induction of <term id="T11" lex="promoter" sem="DNA_domain_or_region">promoters</term> dependent on these elements is inhibitable by the <term id="T12" lex="immunosuppressant" sem="Organic_compound_other">immunosuppressants</term> <term id="T13" lex="cyclosporin_A" sem="Organic_compound_other">cyclosporin A</term> (<term id="T14" lex="CsA" sem="Organic_compound_other">CsA</term>) and <term id="T15" lex="tacrolimus" sem="Organic_compound_other">tacrolimus</term> (<term id="T16" lex="FK-506" sem="Organic_compound_other">FK-506</term>).</sentence>
<event KT="Other" id="E2">
<type class="Positive_regulation"/>
<theme idref="T5"/>
<cause idref="T8"/>
<clue>The <clueType>induction</clueType> <linkTheme>of</linkTheme> <corefTheme>promoters</corefTheme> <linkCause>dependent on</linkCause> <corefCause>these elements</corefCause> is inhibitable by the immunosuppressants cyclosporin A (CsA) and tacrolimus (FK-506).</clue>
</event>
<event KT="Fact" id="E3">
<type class="Negative_regulation"/>
<theme idref="E2"/>
<cause idref="T14"/>
<clue>The induction of promoters dependent on these elements is <clueType>inhibitable</clueType> <linkCause>by</linkCause> the immunosuppressants cyclosporin A (CsA) and tacrolimus (FK-506).</clue>
</event>
<event KT="Fact" id="E4">
<type class="Negative_regulation"/>
<theme idref="E2"/>
<cause idref="T16"/>
<clue>The induction of promoters dependent on these elements is <clueType>inhibitable</clueType> <linkCause>by</linkCause> the immunosuppressants cyclosporin A (CsA) and tacrolimus (FK-506).</clue>
</event>
<sentence id="S4"><term id="T17" lex="calcineurin" sem="Protein_molecule">Calcineurin</term>, a <term id="T18" lex="Ca2+/calmodulin-dependent_protein_phosphatase" sem="Protein_molecule"><term id="T19" lex="Ca2+" sem="Element">Ca2+</term>/calmodulin-dependent protein phosphatase</term>, is the <term id="T20" lex="FK-506" sem="Organic_compound_other">FK-506</term>- and <term id="T21" lex="CsA" sem="Organic_compound_other">CsA</term>-sensitive enzyme required for <term id="A1" sem="Protein_family_or_group">TcR</term> mediated activation of the <term id="T22" lex="IL-2_promoter" sem="DNA_domain_or_region">IL-2 promoter</term>.</sentence>
<event KT="Other" id="E5">
<type/>
<theme idref="T17"/>
<cause idref="T20"/>
<clue>Calcineurin, a Ca2+/calmodulin-dependent protein phosphatase, is the FK-506- and CsA-<clueType>sensitive</clueType> enzyme required for TcR mediated activation of the IL-2 promoter.</clue>
<comment>SENSITIVITY</comment></event>
<event KT="Other" id="E6">
<type/>
<theme idref="T17"/>
<cause idref="T21"/>
<clue>Calcineurin, a Ca2+/calmodulin-dependent protein phosphatase, is the FK-506- and CsA-<clueType>sensitive</clueType> enzyme required for TcR mediated activation of the IL-2 promoter.</clue>
<comment>SENSITIVITY</comment></event>
<event KT="Other" id="E7">
<type class="Positive_regulation"/>
<theme idref="T22"/>
<cause idref="A1"/>
<clue>Calcineurin, a Ca2+/calmodulin-dependent protein phosphatase, is the FK-506- and CsA-sensitive enzyme required for TcR <linkCause>mediated</linkCause> <clueType>activation</clueType> <linkTheme>of</linkTheme> the IL-2 promoter.</clue>
</event>
<event KT="Fact" id="E9">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T17"/>
<clue>Calcineurin, a Ca2+/calmodulin-dependent protein phosphatase, is the FK-506- and CsA-sensitive enzyme <clueType>required</clueType> <linkTheme>for</linkTheme> TcR mediated activation of the IL-2 promoter.</clue>
</event>
<sentence id="S5">We report that a constitutively active form of <term id="T23" lex="calcineurin" sem="Protein_molecule">calcineurin</term> partially substitutes for the <term id="T24" lex="Ca2+_co-stimulus" sem="Other"><term id="T25" lex="Ca2+" sem="Element">Ca2+</term> co-stimulus</term> required to activate the <term id="T26" lex="IL-2_promoter_element" sem="DNA_domain_or_region"><term id="T27" lex="IL-2_promoter" sem="DNA_domain_or_region">IL-2 promoter</term> elements</term> <term id="T28" lex="IL-2A" sem="DNA_domain_or_region">IL-2A</term> (which binds the factors <term id="T29" lex="OAP" sem="Protein_molecule">OAP</term> and <term id="T30" lex="Oct-1" sem="Protein_molecule">Oct-1</term>) and <term id="T31" lex="IL-2E" sem="DNA_domain_or_region">IL-2E</term> (which binds <term id="T32" lex="NF-AT" sem="Protein_family_or_group">NF-AT</term>), and completely substitutes for the <term id="T33" lex="Ca2+_co-stimulus" sem="Other"><term id="T34" lex="Ca2+" sem="Element">Ca2+</term> co-stimulus</term> required to stimulate an <term id="A2" sem="DNA_domain_or_region"><term id="T35" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>-dependent element</term>.</sentence>
<event KT="Other" id="E10">
<type class="Positive_regulation"/>
<theme idref="T28"/>
<cause idref="T24"/>
<clue>We report that a constitutively active form of calcineurin partially substitutes for the Ca2+ co-stimulus required to <clueType>activate</clueType> the IL-2 promoter elements IL-2A (which binds the factors OAP and Oct-1) and IL-2E (which binds NF-AT), and completely substitutes for the Ca2+ co-stimulus required to stimulate an NF-kappa B-dependent element.</clue>
</event>
<event KT="Other" id="E11">
<type class="Positive_regulation"/>
<theme idref="T31"/>
<cause idref="T24"/>
<clue>We report that a constitutively active form of calcineurin partially substitutes for the Ca2+ co-stimulus required to <clueType>activate</clueType> the IL-2 promoter elements IL-2A (which binds the factors OAP and Oct-1) and IL-2E (which binds NF-AT), and completely substitutes for the Ca2+ co-stimulus required to stimulate an NF-kappa B-dependent element.</clue>
</event>
<event KT="Analysis" id="E50">
<type class="Positive_regulation"/>
<theme idref="T28"/>
<cause idref="T23"/>
<clue>We <clueKT>report</clueKT> that a constitutively active form of calcineurin <clueType>partially</clueType> substitutes for the Ca2+ co-stimulus required to <clueType>activate</clueType> the IL-2 promoter elements IL-2A (which binds the factors OAP and Oct-1) and IL-2E (which binds NF-AT), and completely substitutes for the Ca2+ co-stimulus required to stimulate an NF-kappa B-dependent element.</clue>
</event>
<event KT="Analysis" id="E51">
<type class="Positive_regulation"/>
<theme idref="T31"/>
<cause idref="T23"/>
<clue>We <clueKT>report</clueKT> that a constitutively active form of calcineurin <clueType>partially</clueType> substitutes for the Ca2+ co-stimulus required to <clueType>activate</clueType> the IL-2 promoter elements IL-2A (which binds the factors OAP and Oct-1) and IL-2E (which binds NF-AT), and completely substitutes for the Ca2+ co-stimulus required to stimulate an NF-kappa B-dependent element.</clue>
</event>
<event KT="Analysis" id="E12">
<type class="Positive_regulation"/>
<theme idref="A2"/>
<cause idref="T33"/>
<clue>We <clueKT>report</clueKT> that a constitutively active form of calcineurin partially substitutes for the Ca2+ co-stimulus required to activate the IL-2 promoter elements IL-2A (which binds the factors OAP and Oct-1) and IL-2E (which binds NF-AT), and completely substitutes for the Ca2+ co-stimulus required to <clueType>stimulate</clueType> an NF-kappa B-dependent element.</clue>
</event>
<event KT="Analysis" id="E52">
<type class="Positive_regulation"/>
<theme idref="A2"/>
<cause idref="T23"/>
<clue>We <clueKT>report</clueKT> that a constitutively active form of calcineurin partially substitutes for the Ca2+ co-stimulus required to activate the IL-2 promoter elements IL-2A (which binds the factors OAP and Oct-1) and IL-2E (which binds NF-AT), and completely substitutes for the Ca2+ co-stimulus required to <clueType>stimulate</clueType> an NF-kappa B-dependent element.</clue>
</event>
<event KT="Fact" id="E23">
<type class="Binding"/>
<theme idref="T28"/>
<theme idref="T29"/>
<clue>We report that a constitutively active form of calcineurin partially substitutes for the Ca2+ co-stimulus required to activate the IL-2 promoter elements IL-2A (which <clueType>binds</clueType> the factors OAP and Oct-1) and IL-2E (which binds NF-AT), and completely substitutes for the Ca2+ co-stimulus required to stimulate an NF-kappa B-dependent element.</clue>
</event>
<event KT="Fact" id="E24">
<type class="Binding"/>
<theme idref="T28"/>
<theme idref="T30"/>
<clue>We report that a constitutively active form of calcineurin partially substitutes for the Ca2+ co-stimulus required to activate the IL-2 promoter elements IL-2A (which <clueType>binds</clueType> the factors OAP and Oct-1) and IL-2E (which binds NF-AT), and completely substitutes for the Ca2+ co-stimulus required to stimulate an NF-kappa B-dependent element.</clue>
</event>
<event KT="Fact" id="E25">
<type class="Binding"/>
<theme idref="T31"/>
<theme idref="T32"/>
<clue>We report that a constitutively active form of calcineurin partially substitutes for the Ca2+ co-stimulus required to activate the IL-2 promoter elements IL-2A (which binds the factors OAP and Oct-1) and IL-2E (which <clueType>binds</clueType> NF-AT), and completely substitutes for the Ca2+ co-stimulus required to stimulate an NF-kappa B-dependent element.</clue>
</event>
<sentence id="S6"><term id="T36" lex="calcineurin" sem="Protein_molecule">Calcineurin</term> stimulates the <term id="T37" lex="NF-kappa_B_element" sem="DNA_domain_or_region"><term id="T38" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> element</term> by enhancing inactivation of <term id="T39" lex="I_kappa_B/MAD3" sem="Protein_molecule">I kappa B/MAD3</term>, an inhibitor of <term id="T40" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>, thereby increasing the amount of nuclear <term id="T41" lex="NF-kappa_B_DNA_binding_activity" sem="Other"><term id="T42" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> <term id="A5" sem="DNA_molecule">DNA</term> binding activity</term>.</sentence>
<event id="E13">
<type class="Negative_regulation"/>
<theme idref="T39"/>
<clue>Calcineurin stimulates the NF-kappa B element by enhancing <clueType>inactivation</clueType> <linkTheme>of</linkTheme> I kappa B/MAD3, an inhibitor of NF-kappa B, thereby increasing the amount of nuclear NF-kappa B DNA binding activity.</clue>
</event>
<event id="E14">
<type class="Positive_regulation"/>
<theme idref="E13"/>
<cause idref="T36"/>
<clue>Calcineurin stimulates the NF-kappa B element by <clueType>enhancing</clueType> inactivation of I kappa B/MAD3, an inhibitor of NF-kappa B, thereby increasing the amount of nuclear NF-kappa B DNA binding activity.</clue>
</event>
<event id="E15">
<type class="Positive_regulation"/>
<theme idref="T37"/>
<cause idref="E14"/>
<clue>Calcineurin <clueType>stimulates</clueType> the NF-kappa B element <linkCause>by</linkCause> enhancing inactivation of I kappa B/MAD3, an inhibitor of NF-kappa B, thereby increasing the amount of nuclear NF-kappa B DNA binding activity.</clue>
</event>
<event KT="Other" id="E26">
<type class="Binding"/>
<theme idref="T42"/>
<theme idref="A5"/>
<clue>Calcineurin stimulates the NF-kappa B element by enhancing inactivation of I kappa B/MAD3, an inhibitor of NF-kappa B, thereby increasing the amount of <clueLoc>nuclear</clueLoc> NF-kappa B DNA <clueType>binding</clueType> activity.</clue>
</event>
<event KT="Analysis" id="E16">
<type class="Positive_regulation"/>
<theme idref="E26"/>
<cause idref="E15"/>
<clue>Calcineurin stimulates the NF-kappa B element by enhancing inactivation of I kappa B/MAD3, an inhibitor of NF-kappa B, <linkCause><clueKT>thereby</clueKT></linkCause> <clueType>increasing</clueType> the amount of nuclear NF-kappa B DNA binding activity.</clue>
</event>
<event KT="Fact" id="E53">
<type class="Negative_regulation"/>
<theme idref="T40"/>
<cause idref="T39"/>
<clue>Calcineurin stimulates the NF-kappa B element by enhancing inactivation of I kappa B/MAD3, an <clueType>inhibitor</clueType> <linkTheme>of</linkTheme> NF-kappa B, thereby increasing the amount of nuclear NF-kappa B DNA binding activity.</clue>
</event>
<sentence id="S7">These data provide the first demonstration <term id="T43" lex="in_vivo" sem="Other">in vivo</term> that activation of a <term id="T44" lex="protein_phosphatase" sem="Protein_family_or_group">protein phosphatase</term> can inactivate <term id="T45" lex="I_kappa_B" sem="Protein_molecule">I kappa B</term>, and suggest one possible explanation for <term id="T46" lex="mechanism-based_toxicity" sem="Other">mechanism-based toxicities</term> associated with <term id="T47" lex="FK-506" sem="Organic_compound_other">FK-506</term> and <term id="T48" lex="CsA" sem="Organic_compound_other">CsA</term> by demonstrating that these drugs can inhibit the <term id="T49" lex="calcineurin-dependent_activation" sem="Other"><term id="T50" lex="calcineurin" sem="Protein_molecule">calcineurin</term>-dependent activation</term> of a virtually <term id="T51" lex="ubiquitous_transcription_factor" sem="Protein_family_or_group">ubiquitous transcription factor</term>.</sentence>
<event KT="Other" id="E17">
<type class="Positive_regulation"/>
<theme idref="T44"/>
<clue>These data provide the first demonstration in vivo that <clueType>activation</clueType> <linkTheme>of</linkTheme> a protein phosphatase can inactivate I kappa B, and suggest one possible explanation for mechanism-based toxicities associated with FK-506 and CsA by demonstrating that these drugs can inhibit the calcineurin-dependent activation of a virtually ubiquitous transcription factor.</clue>
</event>
<event CL="L2" KT="Analysis" id="E18">
<type class="Negative_regulation"/>
<theme idref="T45"/>
<cause idref="E17"/>
<clue>These data provide the first <clueKT>demonstration</clueKT> in vivo that activation of a protein phosphatase <clueCL>can</clueCL> <clueType>inactivate</clueType> I kappa B, and suggest one possible explanation for mechanism-based toxicities associated with FK-506 and CsA by demonstrating that these drugs can inhibit the calcineurin-dependent activation of a virtually ubiquitous transcription factor.</clue>
</event>
<event KT="Other" id="E19">
<type class="Positive_regulation"/>
<theme idref="T51"/>
<cause idref="T50"/>
<clue>These data provide the first demonstration in vivo that activation of a protein phosphatase can inactivate I kappa B, and suggest one possible explanation for mechanism-based toxicities associated with FK-506 and CsA by demonstrating that these drugs can inhibit the calcineurin-<linkCause>dependent</linkCause> <clueType>activation</clueType> <linkTheme>of</linkTheme> a virtually ubiquitous transcription factor.</clue>
</event>
<event CL="L2" KT="Analysis" id="E20">
<type class="Negative_regulation"/>
<theme idref="E19"/>
<cause idref="T47"/>
<clue>These data provide the first demonstration in vivo that activation of a protein phosphatase can inactivate I kappa B, and suggest one possible explanation for mechanism-based toxicities associated with FK-506 and CsA by <clueKT>demonstrating</clueKT> that <corefCause>these drugs</corefCause> <clueCL>can</clueCL> <clueType>inhibit</clueType> the calcineurin-dependent activation of a virtually ubiquitous transcription factor.</clue>
</event>
<event CL="L2" KT="Analysis" id="E21">
<type class="Negative_regulation"/>
<theme idref="E19"/>
<cause idref="T48"/>
<clue>These data provide the first demonstration in vivo that activation of a protein phosphatase can inactivate I kappa B, and suggest one possible explanation for mechanism-based toxicities associated with FK-506 and CsA by <clueKT>demonstrating</clueKT> that <corefCause>these drugs</corefCause> <clueCL>can</clueCL> <clueType>inhibit</clueType> the calcineurin-dependent activation of a virtually ubiquitous transcription factor.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
